Cite
HARVARD Citation
Kruse, V. et al. (n.d.). Sunitinib for metastatic renal cell cancer patients: observational study highlighting the risk of important drug–drug interactions. Journal of clinical pharmacy and therapeutics. pp. 259-265. [Online].